TG Therapeutics, Inc. (TGTX) financial statements (2021 and earlier)

Company profile

Business Address 2 GANSEVOORT STREET, 9TH FLOOR
NEW YORK, NY 10014
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:60514069854510279
Cash and cash equivalents5531134257255556
Short-term investments52282728202223
Other undisclosed cash, cash equivalents, and short-term investments(0)(0)   250
Receivables  00000
Other current assets1100000
Other undisclosed current assets581086(16)6
Total current assets:6121497993518785
Noncurrent Assets
Operating lease, right-of-use asset99
Property, plant and equipment0000000
Long-term investments and receivables     25 
Long-term investments     25 
Intangible assets, net (including goodwill)1111111
Goodwill1111111
Regulated entity, other noncurrent assets12     
Restricted cash and investments1 11111
Other noncurrent assets    000
Other undisclosed noncurrent assets11222  
Total noncurrent assets:1414544272
TOTAL ASSETS:62616384975511387
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:373036261594
Other undisclosed accounts payable and accrued liabilities373036261594
Debt24200000
Deferred compensation liability8422111
Deferred revenue and credits0000
Other liabilities1849     
Other undisclosed current liabilities  0    
Total current liabilities:8884392817115
Noncurrent Liabilities
Long-term debt and lease obligation1839     
Long-term debt, excluding current maturities829     
Operating lease, liability1010
Liabilities, other than long-term debt11202212
Deferred revenue and credits2212
Deferred revenue11
Deferred rent credit  1
Other liabilities  18    
Other undisclosed noncurrent liabilities  1    
Total noncurrent liabilities:1940212212
Total liabilities:106124603019127
Stockholders' equity
Stockholders' equity attributable to parent5193924673610280
Common stock0000000
Treasury stock, value(0)(0)(0)(0)(0)(0)(0)
Additional paid in capital1,500740553422272260175
Accumulated deficit(981)(701)(528)(355)(236)(158)(95)
Other undisclosed stockholders' equity     00
Total stockholders' equity:5193924673610280
TOTAL LIABILITIES AND EQUITY:62616384975511387

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenue, net0000
Amortization of lease incentives(0)(0) 
Other income110   
Gross profit:0000000
Operating expenses(274)(169)(175)(119)(79)(63)(56)
Operating loss:(274)(169)(174)(119)(79)(63)(56)
Nonoperating income (expense)(6)(4)1010(0)
Investment income, nonoperating000(0)(0)(1)(0)
Interest and debt expense(6)(5)   (1)(1)
Other undisclosed income from continuing operations before equity method investments, income taxes65   11
Net loss available to common stockholders, diluted:(279)(173)(173)(118)(78)(63)(56)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(279)(173)(173)(118)(78)(63)(56)
Comprehensive loss, net of tax, attributable to parent:(279)(173)(173)(118)(78)(63)(56)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: